Chinese innovative biotech firm Lepu Biotech completed a nearly RMB1.291 billion(US$186 million) series B round of financing co-led by Riverhead Capital, Sunshine Insurance Group and Ping An Capital.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
